234 results on '"Blum, Yuna"'
Search Results
2. Cirscan: a shiny application to identify differentially active sponge mechanisms and visualize circRNA–miRNA–mRNA networks
3. Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma
4. Difference in Pap test uptake between women who have sex with women and other women in France: A comparative survey of 2032 women
5. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort
6. Abstract B064: Redefining phenotypic heterogeneity of pancreatic ductal adenocarcinoma: A bottom-up approach
7. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
8. Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach
9. Cirscan: a shiny application to identify differentially active sponge mechanisms and visualize circRNA-miRNA-mRNA networks.
10. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
11. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
12. Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
13. Supplementary Table S4 from Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
14. Supplementary Figure S5 from Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
15. Data from Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
16. Depicting the genetic architecture of pediatric cancers through an integrative gene network approach
17. Data from Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
18. Data from Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
19. Supplementary Data from Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
20. Supplementary Data from Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
21. Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
22. Ephrin-B1 regulates the adult diastolic function through a late postnatal maturation of cardiomyocyte surface crests
23. Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
24. Author response: Ephrin-B1 regulates the adult diastolic function through a late postnatal maturation of cardiomyocyte surface crests
25. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4 /6 inhibition
26. Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition
27. Crest maturation at the cardiomyocyte surface contributes to a new late postnatal development stage that controls the diastolic function of the adult heart
28. PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides
29. Abstract 3128: Spatial intra-tumor molecular heterogeneity in malignant pleural mesothelioma
30. Additional file 1 of DECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification
31. Additional file 2 of Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
32. Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
33. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target
34. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target.
35. Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features
36. A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
37. Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
38. Genetic alterations of malignant pleural mesothelioma: association to tumor heterogeneity and overall survival Author names
39. From Xenograft epigenomics to therapeutic opportunities
40. Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
41. Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
42. PDAC Arising in Young and Old Patients Display Similar Molecular Features
43. Chicken adaptive response to low energy diet: main role of the hypothalamic lipid metabolism revealed by a phenotypic and multi-tissue transcriptomic approach
44. Multi-omic approaches unveil new therapeutic targets for the treatment of pancreatic cancer
45. Unraveling the cellular heterogeneity of malignant pleural mesothelioma through a deconvolution approach
46. Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset
47. Complex trait subtypes identification using transcriptome profiling reveals an interaction between two QTL affecting adiposity in chicken
48. SMAP: exploiting high-throughput sequencing data of patient derived xenografts
49. A factor model to analyze heterogeneity in gene expression
50. Additional file 2: Figure S1. of Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.